+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antimicrobial Suture Market Size, Share & Trends Analysis Report by Type (Absorbable and Non Absorbable), End User (Hospitals, Clinics, and Others), Regional Outlook and Forecast, 2024-2031

  • PDF Icon

    Report

  • 183 Pages
  • August 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5996342
The Global Antimicrobial Suture Market size is expected to reach $367.5 million by 2031, rising at a market growth of 3.5% CAGR during the forecast period.

North America, especially the United States and Canada, has some of the most advanced healthcare systems in the world. The emphasis on high standards of care drives the adoption of advanced medical products, including antimicrobial sutures, to ensure the best outcomes for patients. The region strongly focuses on infection control measures in hospitals and outpatient settings. Antimicrobial sutures meet these stringent infection control standards and prevent complications from surgical site infections. Thus, the North America 37% region acquired revenue share in the market 2023.



Hospitals and surgical centers are increasingly adopting stringent infection control protocols to improve patient safety and minimize the risk of postoperative infections. Antimicrobial sutures play a crucial role in these protocols by reducing the incidence of infections at the surgical site.

Additionally, as healthcare expenditure rises, there is greater investment in advanced medical technologies and products, including antimicrobial sutures. Healthcare facilities with increased budgets can afford to incorporate the latest innovations, such as antimicrobial sutures, to improve patient care and infection control.

However, many healthcare facilities, especially those with limited budgets, may struggle to justify the higher cost of antimicrobial sutures compared to traditional sutures. Budget constraints can limit the ability of these facilities to invest in advanced technologies, potentially leading to a preference for more cost-effective alternatives. Thus, the high cost of antimicrobial sutures hampers the market's growth.

The pandemic caused interruptions in clinical trials and research for new antimicrobial sutures. Delays in research and development affected the progress of innovative products and solutions. With a shift in focus towards COVID-19-related research, developing and testing antimicrobial sutures faced delays. This shift impacted on the introduction of new and improved products in the market. Thus, the COVID-19 pandemic had a negative impact on the market.

Driving and Restraining Factors

Drivers

  • Growing focus on infection control protocols
  • Increasing healthcare expenditure worldwide
  • Rising incidence of surgical site infections (SSIs)

Restraints

  • High cost of antimicrobial sutures
  • Increasing competition from alternative technologies

Opportunities

  • Rising demand for minimally invasive surgeries
  • Growth in sports medicine

Challenges

  • Potential for antimicrobial resistance
  • High replacement rate of antimicrobial sutures

End Use Outlook

On the basis of end user, the market is segmented into hospitals, clinics, and others. The hospitals segment recorded 68% revenue share in the market in 2023. Hospitals perform many surgeries daily across various specialties, including general surgery, orthopedics, cardiology, and gynecology.



Type Outlook

Based on type, the market is divided into absorbable and non-absorbable. The non-absorbable segment procured 33% revenue share in the market in 2023. Non-absorbable sutures provide long-term support for tissues that require prolonged stabilization, making them ideal for high-tension areas or where long-term durability is essential.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2023, the Asia Pacific region generated 26% revenue share in the market. With the growth of healthcare facilities and advancements in medical technology, there has been an increase in the number of surgical procedures performed in the Asia-Pacific region.

List of Key Companies Profiled

  • Conmed Corporation
  • Smith & Nephew plc
  • Demetech Corporation
  • Medtronic PLC
  • Braun Melsungen AG
  • W.L. Gore & Associates, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Peters Surgical
  • Stryker Corporation

Market Report Segmentation

By Type

  • Absorbable
  • Non absorbable

By End User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Antimicrobial Suture Market, by Type
1.4.2 Global Antimicrobial Suture Market, by End User
1.4.3 Global Antimicrobial Suture Market, by Geography
1.5 Methodology for the Research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Global Antimicrobial Suture Market by Type
4.1 Global Absorbable Market by Region
4.2 Global Non absorbable Market by Region
Chapter 5. Global Antimicrobial Suture Market by End User
5.1 Global Hospitals Market by Region
5.2 Global Clinics Market by Region
5.3 Global Others Market by Region
Chapter 6. Global Antimicrobial Suture Market by Region
6.1 North America Antimicrobial Suture Market
6.1.1 North America Antimicrobial Suture Market by Type
6.1.1.1 North America Absorbable Market by Region
6.1.1.2 North America Non absorbable Market by Region
6.1.2 North America Antimicrobial Suture Market by End User
6.1.2.1 North America Hospitals Market by Country
6.1.2.2 North America Clinics Market by Country
6.1.2.3 North America Others Market by Country
6.1.3 North America Antimicrobial Suture Market by Country
6.1.3.1 US Antimicrobial Suture Market
6.1.3.1.1 US Antimicrobial Suture Market by Type
6.1.3.1.2 US Antimicrobial Suture Market by End User
6.1.3.2 Canada Antimicrobial Suture Market
6.1.3.2.1 Canada Antimicrobial Suture Market by Type
6.1.3.2.2 Canada Antimicrobial Suture Market by End User
6.1.3.3 Mexico Antimicrobial Suture Market
6.1.3.3.1 Mexico Antimicrobial Suture Market by Type
6.1.3.3.2 Mexico Antimicrobial Suture Market by End User
6.1.3.4 Rest of North America Antimicrobial Suture Market
6.1.3.4.1 Rest of North America Antimicrobial Suture Market by Type
6.1.3.4.2 Rest of North America Antimicrobial Suture Market by End User
6.2 Europe Antimicrobial Suture Market
6.2.1 Europe Antimicrobial Suture Market by Type
6.2.1.1 Europe Absorbable Market by Country
6.2.1.2 Europe Non absorbable Market by Country
6.2.2 Europe Antimicrobial Suture Market by End User
6.2.2.1 Europe Hospitals Market by Country
6.2.2.2 Europe Clinics Market by Country
6.2.2.3 Europe Others Market by Country
6.2.3 Europe Antimicrobial Suture Market by Country
6.2.3.1 Germany Antimicrobial Suture Market
6.2.3.1.1 Germany Antimicrobial Suture Market by Type
6.2.3.1.2 Germany Antimicrobial Suture Market by End User
6.2.3.2 UK Antimicrobial Suture Market
6.2.3.2.1 UK Antimicrobial Suture Market by Type
6.2.3.2.2 UK Antimicrobial Suture Market by End User
6.2.3.3 France Antimicrobial Suture Market
6.2.3.3.1 France Antimicrobial Suture Market by Type
6.2.3.3.2 France Antimicrobial Suture Market by End User
6.2.3.4 Russia Antimicrobial Suture Market
6.2.3.4.1 Russia Antimicrobial Suture Market by Type
6.2.3.4.2 Russia Antimicrobial Suture Market by End User
6.2.3.5 Spain Antimicrobial Suture Market
6.2.3.5.1 Spain Antimicrobial Suture Market by Type
6.2.3.5.2 Spain Antimicrobial Suture Market by End User
6.2.3.6 Italy Antimicrobial Suture Market
6.2.3.6.1 Italy Antimicrobial Suture Market by Type
6.2.3.6.2 Italy Antimicrobial Suture Market by End User
6.2.3.7 Rest of Europe Antimicrobial Suture Market
6.2.3.7.1 Rest of Europe Antimicrobial Suture Market by Type
6.2.3.7.2 Rest of Europe Antimicrobial Suture Market by End User
6.3 Asia Pacific Antimicrobial Suture Market
6.3.1 Asia Pacific Antimicrobial Suture Market by Type
6.3.1.1 Asia Pacific Absorbable Market by Country
6.3.1.2 Asia Pacific Non absorbable Market by Country
6.3.2 Asia Pacific Antimicrobial Suture Market by End User
6.3.2.1 Asia Pacific Hospitals Market by Country
6.3.2.2 Asia Pacific Clinics Market by Country
6.3.2.3 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Antimicrobial Suture Market by Country
6.3.3.1 China Antimicrobial Suture Market
6.3.3.1.1 China Antimicrobial Suture Market by Type
6.3.3.1.2 China Antimicrobial Suture Market by End User
6.3.3.2 Japan Antimicrobial Suture Market
6.3.3.2.1 Japan Antimicrobial Suture Market by Type
6.3.3.2.2 Japan Antimicrobial Suture Market by End User
6.3.3.3 India Antimicrobial Suture Market
6.3.3.3.1 India Antimicrobial Suture Market by Type
6.3.3.3.2 India Antimicrobial Suture Market by End User
6.3.3.4 South Korea Antimicrobial Suture Market
6.3.3.4.1 South Korea Antimicrobial Suture Market by Type
6.3.3.4.2 South Korea Antimicrobial Suture Market by End User
6.3.3.5 Australia Antimicrobial Suture Market
6.3.3.5.1 Australia Antimicrobial Suture Market by Type
6.3.3.5.2 Australia Antimicrobial Suture Market by End User
6.3.3.6 Malaysia Antimicrobial Suture Market
6.3.3.6.1 Malaysia Antimicrobial Suture Market by Type
6.3.3.6.2 Malaysia Antimicrobial Suture Market by End User
6.3.3.7 Rest of Asia Pacific Antimicrobial Suture Market
6.3.3.7.1 Rest of Asia Pacific Antimicrobial Suture Market by Type
6.3.3.7.2 Rest of Asia Pacific Antimicrobial Suture Market by End User
6.4 LAMEA Antimicrobial Suture Market
6.4.1 LAMEA Antimicrobial Suture Market by Type
6.4.1.1 LAMEA Absorbable Market by Country
6.4.1.2 LAMEA Non absorbable Market by Country
6.4.2 LAMEA Antimicrobial Suture Market by End User
6.4.2.1 LAMEA Hospitals Market by Country
6.4.2.2 LAMEA Clinics Market by Country
6.4.2.3 LAMEA Others Market by Country
6.4.3 LAMEA Antimicrobial Suture Market by Country
6.4.3.1 Brazil Antimicrobial Suture Market
6.4.3.1.1 Brazil Antimicrobial Suture Market by Type
6.4.3.1.2 Brazil Antimicrobial Suture Market by End User
6.4.3.2 Argentina Antimicrobial Suture Market
6.4.3.2.1 Argentina Antimicrobial Suture Market by Type
6.4.3.2.2 Argentina Antimicrobial Suture Market by End User
6.4.3.3 UAE Antimicrobial Suture Market
6.4.3.3.1 UAE Antimicrobial Suture Market by Type
6.4.3.3.2 UAE Antimicrobial Suture Market by End User
6.4.3.4 Saudi Arabia Antimicrobial Suture Market
6.4.3.4.1 Saudi Arabia Antimicrobial Suture Market by Type
6.4.3.4.2 Saudi Arabia Antimicrobial Suture Market by End User
6.4.3.5 South Africa Antimicrobial Suture Market
6.4.3.5.1 South Africa Antimicrobial Suture Market by Type
6.4.3.5.2 South Africa Antimicrobial Suture Market by End User
6.4.3.6 Nigeria Antimicrobial Suture Market
6.4.3.6.1 Nigeria Antimicrobial Suture Market by Type
6.4.3.6.2 Nigeria Antimicrobial Suture Market by End User
6.4.3.7 Rest of LAMEA Antimicrobial Suture Market
6.4.3.7.1 Rest of LAMEA Antimicrobial Suture Market by Type
6.4.3.7.2 Rest of LAMEA Antimicrobial Suture Market by End User
Chapter 7. Company Profiles
7.1 ConMed Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Smith & Nephew PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional and Segmental Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 DemeTECH Corporation
7.3.1 Company Overview
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 B. Braun Melsungen AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 W. L. Gore & Associates, Inc.
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Boston Scientific Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 SWOT Analysis
7.8 Johnson & Johnson
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental & Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Peters Surgical
7.9.1 Company Overview
7.10. Stryker Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 SWOT Analysis
Chapter 8. Winning Imperatives for Antimicrobial Suture Market

Companies Mentioned

  • Conmed Corporation
  • Smith & Nephew plc
  • Demetech Corporation
  • Medtronic PLC
  • B. Braun Melsungen AG
  • W. L. Gore & Associates, Inc.
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Peters Surgical
  • Stryker Corporation

Methodology

Loading
LOADING...

Table Information